- Investing Ideas
- /
- Global Healthcare Undervalued over 20% based on DCF
Global Healthcare Undervalued over 20% based on DCF
UPDATED May 14, 2024
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
203 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HCA | US$320.50 | 1.9% | 16.3% | US$83.1b | US$344.35 | PE15.3x | E6.0% | 0.8% | ||
BDX | US$235.00 | -0.9% | -6.1% | US$68.5b | US$278.82 | PE49.8x | E17.8% | 1.6% | ||
SHL | €53.08 | 2.1% | -0.9% | €59.2b | €60.47 | PE32.2x | E17.2% | 1.8% | ||
COR | US$221.94 | -2.1% | 27.1% | US$44.5b | US$254.47 | PE23.9x | E10.2% | 0.9% | ||
VEEV | US$203.82 | -0.7% | 21.6% | US$32.9b | US$241.82 | PE62.7x | E16.7% | n/a | ||
RMD | US$215.85 | -0.1% | -5.6% | US$32.0b | US$216.65 | PE33.1x | E13.1% | 0.9% | ||
STE | US$236.00 | 10.9% | 13.5% | US$23.0b | US$243.00 | PE42.3x | E15.8% | 0.9% | ||
SOON | CHF285.80 | 7.0% | 14.9% | CHF17.0b | CHF272.06 | PE28.4x | E11.0% | 1.6% | ||
COO | US$95.96 | 2.7% | -1.0% | US$18.5b | US$107.89 | PE65.6x | E21.8% | 0% | ||
BAX | US$35.24 | -2.4% | -18.1% | US$18.1b | US$46.47 | PS1.2x | E36.3% | 3.3% | ||
300015 | CN¥12.83 | -3.0% | -43.9% | CN¥119.3b | CN¥18.13 | PE34.3x | E18.2% | 1.2% | ||
BIM | €95.25 | -4.6% | -2.6% | €11.3b | €113.40 | PE31.5x | E14.3% | 0.9% | ||
IHH | RM6.27 | -0.6% | 5.9% | RM55.2b | RM7.13 | PE18.7x | E-11.0% | 1.8% | ||
SN. | UK£10.18 | 2.0% | -21.6% | UK£8.9b | UK£13.05 | PE42.5x | E21.7% | 2.9% | ||
TFX | US$212.62 | 5.5% | -13.8% | US$9.8b | US$245.23 | PE33.8x | E17.9% | 0.6% | ||
1099 | HK$22.55 | 10.3% | -15.5% | HK$70.4b | HK$26.61 | PE7.3x | E6.6% | 3.9% | ||
SHL | AU$26.69 | 0.5% | -25.2% | AU$13.3b | AU$30.63 | PE25.4x | E14.2% | 3.9% | ||
GMED | US$62.84 | 22.4% | 11.3% | US$8.6b | US$68.75 | PE127.4x | E40.9% | n/a | ||
RHC | AU$50.79 | -0.8% | -16.1% | AU$11.7b | AU$57.27 | PE52.7x | E17.3% | 1.3% | ||
CTEC | UK£2.62 | 0.5% | 20.3% | UK£5.4b | UK£3.15 | PE51.9x | E21.0% | 1.9% | ||
ENSG | US$118.14 | 0.2% | 29.5% | US$6.6b | US$134.50 | PE30.5x | E17.9% | 0.2% | ||
MASI | US$115.24 | -15.3% | -32.4% | US$6.2b | US$151.89 | PE77.3x | E33.9% | n/a | ||
XRAY | US$28.12 | -0.5% | -30.4% | US$5.9b | US$33.82 | PS1.5x | E40.1% | 2.3% | ||
GETI B | kr217.10 | -7.8% | -14.0% | kr59.1b | kr233.11 | PE25.9x | E13.1% | 2.0% |